Republic Technologies Statistics
Total Valuation
CSE:DOCT has a market cap or net worth of CAD 4.10 million. The enterprise value is 3.20 million.
| Market Cap | 4.10M |
| Enterprise Value | 3.20M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:DOCT has 32.79 million shares outstanding. The number of shares has increased by 174.22% in one year.
| Current Share Class | 32.79M |
| Shares Outstanding | 32.79M |
| Shares Change (YoY) | +174.22% |
| Shares Change (QoQ) | +4.52% |
| Owned by Insiders (%) | 36.99% |
| Owned by Institutions (%) | n/a |
| Float | 17.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 356.95 |
| PB Ratio | 29.98 |
| P/TBV Ratio | 29.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 278.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.77, with a Debt / Equity ratio of 90.13.
| Current Ratio | 0.77 |
| Quick Ratio | 0.52 |
| Debt / Equity | 90.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -16.66 |
| Interest Coverage | -2.81 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -13.08% |
| Return on Invested Capital (ROIC) | -17.44% |
| Return on Capital Employed (ROCE) | -19.15% |
| Weighted Average Cost of Capital (WACC) | 7.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -223,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.88% in the last 52 weeks. The beta is 2.48, so CSE:DOCT's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | -82.88% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.30 |
| Relative Strength Index (RSI) | 42.85 |
| Average Volume (20 Days) | 9,833 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:DOCT had revenue of CAD 11,484 and -2.46 million in losses. Loss per share was -0.09.
| Revenue | 11,484 |
| Gross Profit | -282,679 |
| Operating Income | -1.66M |
| Pretax Income | -2.68M |
| Net Income | -2.46M |
| EBITDA | n/a |
| EBIT | -1.66M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 2.76 million in cash and 12.33 million in debt, with a net cash position of -9.57 million or -0.29 per share.
| Cash & Cash Equivalents | 2.76M |
| Total Debt | 12.33M |
| Net Cash | -9.57M |
| Net Cash Per Share | -0.29 |
| Equity (Book Value) | 136,742 |
| Book Value Per Share | 0.00 |
| Working Capital | -1.64M |
Cash Flow
| Operating Cash Flow | -739,691 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 2.00M |
| Free Cash Flow | -739,691 |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | -14,455.90% |
| Pretax Margin | -23,355.03% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:DOCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -174.22% |
| Shareholder Yield | -174.22% |
| Earnings Yield | -59.99% |
| FCF Yield | -18.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 30, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |